Kibow® Biotech Inc Celebrates Its 22nd Anniversary with Launch of Its Pharmaceutical Division to Develop a Live Biotherapeutic Drug for Chronic Kidney Disease Patients Based on Its Novel "Enteric Dialysis® Technology Platform

Tuesday, October 1, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

*These statements have not been evaluated by the US Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent disease.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Premium Membership Benefits

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store